160 related articles for article (PubMed ID: 16763465)
1. Osteoclast precursors: cytokine-stimulated immunomodulators of inflammatory bone disease.
Boyce BF; Schwarz EM; Xing L
Curr Opin Rheumatol; 2006 Jul; 18(4):427-32. PubMed ID: 16763465
[TBL] [Abstract][Full Text] [Related]
2. Osteoclast precursors, RANKL/RANK, and immunology.
Xing L; Schwarz EM; Boyce BF
Immunol Rev; 2005 Dec; 208():19-29. PubMed ID: 16313338
[TBL] [Abstract][Full Text] [Related]
3. Regulation of osteoclast precursors in inflammatory bone loss.
Xing L
Curr Opin Investig Drugs; 2009 Nov; 10(11):1195-203. PubMed ID: 19876787
[TBL] [Abstract][Full Text] [Related]
4. Autoimmunity and bone.
Schwarz EM; Looney RJ; Drissi MH; O'Keefe RJ; Boyce BF; Xing L; Ritchlin CT
Ann N Y Acad Sci; 2006 Apr; 1068():275-83. PubMed ID: 16831928
[TBL] [Abstract][Full Text] [Related]
5. Systemic tumor necrosis factor alpha mediates an increase in peripheral CD11bhigh osteoclast precursors in tumor necrosis factor alpha-transgenic mice.
Li P; Schwarz EM; O'Keefe RJ; Ma L; Looney RJ; Ritchlin CT; Boyce BF; Xing L
Arthritis Rheum; 2004 Jan; 50(1):265-76. PubMed ID: 14730625
[TBL] [Abstract][Full Text] [Related]
6. Bone and joint destruction in rheumatoid arthritis: what is really happening?
Goldring SR
J Rheumatol Suppl; 2002 Sep; 65():44-8. PubMed ID: 12236623
[TBL] [Abstract][Full Text] [Related]
7. Cellular and molecular interactions between immune system and bone.
Grcević D; Katavić V; Lukić IK; Kovacić N; Lorenzo JA; Marusić A
Croat Med J; 2001 Aug; 42(4):384-92. PubMed ID: 11471190
[TBL] [Abstract][Full Text] [Related]
8. Osteoclast culture and resorption assays.
Bradley EW; Oursler MJ
Methods Mol Biol; 2008; 455():19-35. PubMed ID: 18463808
[TBL] [Abstract][Full Text] [Related]
9. NF-kappaB inhibitor dehydroxymethylepoxyquinomicin suppresses osteoclastogenesis and expression of NFATc1 in mouse arthritis without affecting expression of RANKL, osteoprotegerin or macrophage colony-stimulating factor.
Kubota T; Hoshino M; Aoki K; Ohya K; Komano Y; Nanki T; Miyasaka N; Umezawa K
Arthritis Res Ther; 2007; 9(5):R97. PubMed ID: 17892600
[TBL] [Abstract][Full Text] [Related]
10. Cytokines regulating osteoclast formation and function.
Lee SK; Lorenzo J
Curr Opin Rheumatol; 2006 Jul; 18(4):411-8. PubMed ID: 16763463
[TBL] [Abstract][Full Text] [Related]
11. Murine dendritic cell transdifferentiation into osteoclasts is differentially regulated by innate and adaptive cytokines.
Speziani C; Rivollier A; Gallois A; Coury F; Mazzorana M; Azocar O; Flacher M; Bella C; Tebib J; Jurdic P; Rabourdin-Combe C; Delprat C
Eur J Immunol; 2007 Mar; 37(3):747-57. PubMed ID: 17304626
[TBL] [Abstract][Full Text] [Related]
12. Osteoclasts, rheumatoid arthritis, and osteoimmunology.
Sato K; Takayanagi H
Curr Opin Rheumatol; 2006 Jul; 18(4):419-26. PubMed ID: 16763464
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo.
Axmann R; Böhm C; Krönke G; Zwerina J; Smolen J; Schett G
Arthritis Rheum; 2009 Sep; 60(9):2747-56. PubMed ID: 19714627
[TBL] [Abstract][Full Text] [Related]
14. TNF-related apoptosis-inducing ligand (TRAIL) induces osteoclast differentiation from monocyte/macrophage lineage precursor cells.
Yen ML; Tsai HF; Wu YY; Hwa HL; Lee BH; Hsu PN
Mol Immunol; 2008 Apr; 45(8):2205-13. PubMed ID: 18206242
[TBL] [Abstract][Full Text] [Related]
15. Review: Immune cells and mediators of inflammatory arthritis.
Schett G
Autoimmunity; 2008 Apr; 41(3):224-9. PubMed ID: 18365836
[TBL] [Abstract][Full Text] [Related]
16. The mechanism of osteoclast differentiation induced by IL-1.
Kim JH; Jin HM; Kim K; Song I; Youn BU; Matsuo K; Kim N
J Immunol; 2009 Aug; 183(3):1862-70. PubMed ID: 19587010
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of Disease: the link between RANKL and arthritic bone disease.
Schett G; Hayer S; Zwerina J; Redlich K; Smolen JS
Nat Clin Pract Rheumatol; 2005 Nov; 1(1):47-54. PubMed ID: 16932627
[TBL] [Abstract][Full Text] [Related]
18. Lipopolysaccharide from Prevotella nigrescens stimulates osteoclastogenesis in cocultures of bone marrow mononuclear cells and primary osteoblasts.
Chung YH; Chang EJ; Kim SJ; Kim HH; Kim HM; Lee SB; Ko JS
J Periodontal Res; 2006 Aug; 41(4):288-96. PubMed ID: 16827722
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-alpha increases circulating osteoclast precursor numbers by promoting their proliferation and differentiation in the bone marrow through up-regulation of c-Fms expression.
Yao Z; Li P; Zhang Q; Schwarz EM; Keng P; Arbini A; Boyce BF; Xing L
J Biol Chem; 2006 Apr; 281(17):11846-55. PubMed ID: 16461346
[TBL] [Abstract][Full Text] [Related]
20. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells.
Fujisaki K; Tanabe N; Suzuki N; Kawato T; Takeichi O; Tsuzukibashi O; Makimura M; Ito K; Maeno M
Life Sci; 2007 Mar; 80(14):1311-8. PubMed ID: 17306833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
